Impact of Opioids on Chemotherapy Induced Gastrointestinal Toxicities

Authors

Olivia Jennings, Virginia Commonwealth University

Original Publication Date

2026

Document Type

Video

Comments

Presented in the New Frontiers in Detecting Disease and Managing Pain session.

Abstract

While advancements in chemotherapy have significantly improved cancer survival rates, gastrointestinal (GI) toxicities remain a life-threatening complication that can compromise treatment efficacy. This presentation investigates how prior and concurrent opioid use—common for pain management in cancer patients—interacts with chemotherapy to worsen GI outcomes.

Clinical data from a single-center study at VCU and a multi-center national study (Trinetix) reveal that prior opioid use triples the risk of chemotherapy dose reductions or treatment delays and doubles the risk of severe GI side effects (e.g., diarrhea, abdominal pain). These delays are independent of cancer type, suggesting a specific pharmacological interaction between opioids and chemotherapeutic agents like irinotecan.

Using a mouse model, the research identifies inflammation and gut dysbiosis as the primary drivers of this toxicity.

Key findings include:

• Macrophage Recruitment: Co-administration of opioids and chemotherapy triggers a massive recruitment of pro-inflammatory, monocyte-derived macrophages to the small intestine, disrupting tissue homeostasis.
• Microbial Dysbiosis: Both drugs independently induce dysbiosis, but co-administration significantly increases the abundance of pathogenic bacteria, particularly species such as Desulfovibrio.
• Hydrogen Sulfide (H₂S) Toxicity: Desulfovibrio produces high levels of H₂S. While H₂S is a necessary signaling molecule at low levels, excessive concentrations alter gut pH, destroy the epithelial barrier, and induce macrophage cell death.
• Therapeutic Potential: Cell culture experiments demonstrate that H₂S scavengers can "mop up" excess gas, preventing macrophage death and potentially mitigating GI damage.

Keywords

Chemotherapy-Induced Gastrointestinal Toxicity (CIGT), Opioid-Chemotherapy interaction, Irinotecan, Gut dysbiosis, Inflammatory response

Rights

Copyright © 2026 Olivia Jennings. All rights reserved.